Evidence map›Paper›PMID 30746156›Full record

ArticleCurrent health sciences journal

Hepatitis C Infection in Hemodialysis Patients.

D C Caragea, A R Mihailovici, C T Streba, M Schenker, B Ungureanu, I N Caragea, R Popa, C Obleaga, C C Vere

Abstract read
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

D C CarageaDepartment of Nephrology, University of Medicine and Pharmacy of Craiova, Romania.
A R MihailoviciDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, Romania.
C T StrebaDepartment of Research Methodology, University of Medicine and Pharmacy of Craiova, Romania.
M SchenkerDepartment of Oncology, University of Medicine and Pharmacy of Craiova, Romania.
B UngureanuDepartment of Gastroenterology, University of Medicine and Pharmacy of Craiova, Romania.
I N CarageaDepartment of Nephrology, University of Medicine and Pharmacy of Craiova, Romania.
R PopaDepartment of Nephrology, University of Medicine and Pharmacy of Craiova, Romania.
C ObleagaDepartment of Surgery, University of Medicine and Pharmacy of Craiova, Romania.
C C VereDepartment of Gastroenterology, University of Medicine and Pharmacy of Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three centuries after the identification of hepatitis C virus (HCV), specialized literature has outlined the epidemiology, viral kinetics and clinical manifestations of this infection. A major cause of morbidity-mortality in patients with renal transplantation and in hemodialysis patients is HCV infection. In high seroprevalence countries, internal accounts are not uniform. The European trend is to decrease the incidence and prevalence of HCV in hemodialysis patients. In Europe, the prevalence of HCV infection among hemodialysis patients tends to be higher than that of the general population, but it is variable by region. Some studies indicate a decrease in incidence in parallel with prevalence in dialysis centers over the last 10 years, while others maintain a high incidence. In some countries, as is the case with Romania, both prevalence and incidence remain high, with the major route of transmission being nosocomial, probably due to limited resources for a rapidly growing dialyzed population. Some authors recommend more isolation measures to be taken in centers with high prevalence of infection.

Indexed as

general datahemodialysishepatitis C virus

Identifiers

PMID30746156
PMCPMC6320456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.